INO earnings date and last-quarter result: next report 2026-08-12, last quarter beat, P/E -0.62. Updated 2026-07-23.
Inovio Pharmaceuticals (INO) Research Hub
Inovio Pharmaceuticals (INO) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.8698 USD (-3.04%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.62, market cap 0.06B. This hub links to the full technical, earnings and options research available for INO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.8698 USD (-3.04%) |
| 52-week range | 0.5632 USD – 1.45 USD |
| Trend regime | Range |
| 14-day RSI | 33.6 (Bearish) |
| Trailing P/E | -0.62 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for INO
Covered Call on INO: how it works, illustrative setup around the real 0.8698 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INO: how it works, illustrative setup around the real 0.8698 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INO: how it works, illustrative setup around the real 0.8698 USD price, max profit/loss, breakeven and when to use it. Educational.
INO technical analysis: range, last 0.8698 USD, RSI 33.6, 52w range 0.5632 USD–1.45 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is INO in?
Inovio Pharmaceuticals (INO) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is INO in an uptrend or downtrend?
As of 2026-10-26, INO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INO's trailing P/E ratio?
INO's trailing P/E is -0.62, with a market cap of 0.06B. See the earnings research page for full valuation detail.
When does INO next report earnings?
INO is next scheduled to report earnings on 2026-08-12.